David G. Watumull is the co-founder of AX3, a consumer longevity company formed to help people be their best selves, longer. AX3 targets inflammaging—a core hallmark of aging—at its source with bio-pure astaxanthin. He is also the co-founder and CEO of Cardax, a life sciences business focused on advancing pharmaceutical and nutraceutical applications of astaxanthin.